Line 114: | Line 114: | ||
</center> | </center> | ||
<br> | <br> | ||
+ | <p> We looked further into the regulations of biotechnology products in Canada and the United and tried to find any piece of legislation that mentioned the regulations of cell-free systems. Within Canada and the United States, both countries do not regulate the methodology of how products are made; they focus on the end materials. While we could not find any specific mention of "cell-free", Ian told us that this may not mean that cell-free systems are not included within the regulations. He suggested that the direct mention of cell-free systems is just out-of-scope of current legislation. However, the closest piece of legislation that we could find that was the most associated with our project is the <i>Assisted Human Reproduction Act </i> in Canada as it prohibits transplanting human-based materials into non-human life forms. </p> | ||
<p> <b><center> Table 2. Canadian and American Regulation Comparisons for Cell-Free Systems. </b> </p> | <p> <b><center> Table 2. Canadian and American Regulation Comparisons for Cell-Free Systems. </b> </p> | ||
<center> | <center> |
Revision as of 17:48, 28 October 2017
Insert Paragraph Discussing What we did and why
Protocol Simplification
Experimental Design
Professional Development
Regulation Research
To understand if synthetic biology products and cell-free systems were regulated around the world, we researched relevant legislation. Table 1 is an overview of the regulations that we could find that are implemented in the four legal systems used as was suggested to us by Ian Andrews (link to silver). We concluded that some legal systems have more concrete regulations for the use of products derived using biotechnology. Most countries have in place some form of assessments to ensure that any products will not have detrimental effects on the environment and human health.
Legal System | Civil | Common | Mixed | Religious |
---|---|---|---|---|
Laboratory Safety | General guidelines implemented, national frameworks being updated |
General guidelines implemented in regulations, committees in place to oversee concerns |
General guidelines implemented in regulations, committees in place to oversee concerns |
National biosafety frameworks in the process of being developed, have signed the Cartagena Protocol |
GMO Regulations | In place, appropriate labelling required in most cases to identify GMO status Generally strict regulations in place (EU, JPN) |
In place, usage differs depending on country though most countries allow (notable exception: NZ) | Dependent on country: some follow EU regulations and restrict access while others are in the process of developing legislation with minimal regulations currently |
In place, only allow certain crops, need proper labelling to identify GMO status |
Environmental Regulations | Environmental impact assessments used to determine effect on biological diversity, environmental release addressed |
Environmental impact assessments used to determine effect on biological diversity, environmental release addressed | Environmental impact assessments used to determine effect on biological diversity, some countries have in place environmental release stipulations |
Environmental impact assessments used to determine effect on biological diversity, developing more specific legislation for environmental release |
Agricultural Regulations | Regulations mostly relate to field trials | Must be approved by regulatory body to not cause a negative impact on the environment |
Dependent on country: some have strict regulations on crops that can be planted while others have regulations in place, but allow a greater crop diversity |
Regulations relate to type of crops that can be planted |
Health Regulations | Must be approved by governing authority to not have negative impacts | Must be approved by governing authority to not have negative impacts | Must be approved by governing authority to not have negative impacts, some countries are still in the process of developing legislation |
In development with the growth of biotechnology, general regulations state that new materials generated must be approved |
We looked further into the regulations of biotechnology products in Canada and the United and tried to find any piece of legislation that mentioned the regulations of cell-free systems. Within Canada and the United States, both countries do not regulate the methodology of how products are made; they focus on the end materials. While we could not find any specific mention of "cell-free", Ian told us that this may not mean that cell-free systems are not included within the regulations. He suggested that the direct mention of cell-free systems is just out-of-scope of current legislation. However, the closest piece of legislation that we could find that was the most associated with our project is the Assisted Human Reproduction Act in Canada as it prohibits transplanting human-based materials into non-human life forms.
Regulation Area | Canada | United States |
---|---|---|
Health | Assisted Human Reproduction Act (HC):
|
Federal Food, Drug, and Cosmetic Act (FDA) Public Health Services Act (FDA):
|
Environment | Canadian Environmental Protection Act (EC and HC):
|
National Environment Policy Act (EPA:
|
Food/Pharmaceuticals | Food and Drugs Act (CFIA):
|
Federal Food, Drug, and Cosmetic Act (FDA) Public Health Service Act (FDA) :
|
Agriculture | Seeds Act (CFIA) Canada Agricultural Products Act (CFIA):
|
Agricultural Act Federal Seed Act (APHIS) Plant Protection Act (APHIS) :
|
Pests | Pest Control Act (PMRA):
|
Federal Insecticide, Fungicide, and Rodenticide Act (EPA):
|
Microorganisms | Canadian Environmental Protection Act (EC and HC):
|
Toxic Substances Control Act (EPA):
|
Animals | Health of Animals Regulations (CFIA):
|
New Animal Drug Application (FDA):
|
Pathogens and Toxins | Human Pathogens and Toxins Act (PHAC):
|
Toxic Substances Control Act (EPA):
|
System Safety Features
The exploration of our plan on how to address the genetic re-coding aspect of our project continues more in depth on our software page. We consider it to be a major part of our human practices, but to explain it as in depth as it requires, we felt it deserved its own page.